Click Here for 5% Off Your First Aladdin Purchase!

ELQ-300 - 98%, high purity , CAS No.1354745-52-0

  • Moligand™
  • ≥98%
Item Number
E412133
Grouped product items
SKUSizeAvailabilityPrice Qty
E412133-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$118.90
E412133-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$189.90
E412133-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$379.90
E412133-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$607.90

Basic Description

SynonymsELQ-300|1354745-52-0|ELQ300|6-chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-one|BRC5YE92RX|6-chloro-7-methoxy-2-methyl-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]-1H-quinolin-4-one|6-Chloro-7-methoxy-2-methyl-3-{4-[4-(tri
Specifications & Purity98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Product Description

Information

ELQ-300, a bioavailable antimalarial agent, is a potent and orally inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1).

Names and Identifiers

IUPAC Name 6-chloro-7-methoxy-2-methyl-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]-1H-quinolin-4-one
INCHI InChI=1S/C24H17ClF3NO4/c1-13-22(23(30)18-11-19(25)21(31-2)12-20(18)29-13)14-3-5-15(6-4-14)32-16-7-9-17(10-8-16)33-24(26,27)28/h3-12H,1-2H3,(H,29,30)
InChi Key WZDNKHCQIZRDKW-UHFFFAOYSA-N
Canonical SMILES CC1=C(C(=O)C2=CC(=C(C=C2N1)OC)Cl)C3=CC=C(C=C3)OC4=CC=C(C=C4)OC(F)(F)F
Isomeric SMILES CC1=C(C(=O)C2=CC(=C(C=C2N1)OC)Cl)C3=CC=C(C=C3)OC4=CC=C(C=C4)OC(F)(F)F
PubChem CID 67016608
Molecular Weight 475.85

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

8 results found

Lot NumberCertificate TypeDateItem
B2419078Certificate of AnalysisJan 06, 2024 E412133
B2419080Certificate of AnalysisJan 06, 2024 E412133
B2419083Certificate of AnalysisJan 06, 2024 E412133
B2419085Certificate of AnalysisJan 06, 2024 E412133
B2419088Certificate of AnalysisJan 06, 2024 E412133
B2419089Certificate of AnalysisJan 06, 2024 E412133
B2419092Certificate of AnalysisJan 06, 2024 E412133
B2419093Certificate of AnalysisJan 06, 2024 E412133

Safety and Hazards(GHS)

Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

Related Documents

References

1. Cross RM, Monastyrskyi A, Mutka TS, Burrows JN, Kyle DE, Manetsch R.  (2010)  Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity..  J Med Chem,  53  (19): (7076-94).  [PMID:20828199]
2. Winter R, Kelly JX, Smilkstein MJ, Hinrichs D, Koop DR, Riscoe MK.  (2011)  Optimization of endochin-like quinolones for antimalarial activity..  Exp Parasitol,  127  (2): (545-51).  [PMID:21040724]
3. Nilsen A, LaCrue AN, White KL, Forquer IP, Cross RM, Marfurt J, Mather MW, Delves MJ, Shackleford DM, Saenz FE et al..  (2013)  Quinolone-3-diarylethers: a new class of antimalarial drug..  Sci Transl Med,  (177): (177ra37).  [PMID:23515079]
4. Stickles AM, de Almeida MJ, Morrisey JM, Sheridan KA, Forquer IP, Nilsen A, Winter RW, Burrows JN, Fidock DA, Vaidya AB et al..  (2015)  Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum..  Antimicrob Agents Chemother,  59  (4): (1977-82).  [PMID:25605352]
5. Miley GP, Pou S, Winter R, Nilsen A, Li Y, Kelly JX, Stickles AM, Mather MW, Forquer IP, Pershing AM et al..  (2015)  ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria..  Antimicrob Agents Chemother,  59  (9): (5555-60).  [PMID:26124159]
6. Frueh L, Li Y, Mather MW, Li Q, Pou S, Nilsen A, Winter RW, Forquer IP, Pershing AM, Xie LH et al..  (2017)  Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria..  ACS Infect Dis,  (10): (728-735).  [PMID:28927276]

Solution Calculators